American Journal of Cardiology
Volume 105, Issue 6 , Pages 804-812 , 15 March 2010

Results of Intracoronary Stem Cell Therapy After Acute Myocardial Infarction

  • Jochen Wöhrle, MD

      Affiliations

    • University of Ulm, Clinic for Internal Medicine II, Ulm, Germany
    • Corresponding Author InformationCorresponding author: Tel: (+49) 731-500-45001; fax: (+49) 731-500-45029
    • ,
  • Nico Merkle, MD

      Affiliations

    • University of Ulm, Clinic for Internal Medicine II, Ulm, Germany
    • ,
  • Volker Mailänder, MD

      Affiliations

    • Institute of Transfusion Medicine and Institute of Clinical Transfusion Medicine and Immunogenetics, Ulm, Germany
    • ,
  • Thorsten Nusser, MD

      Affiliations

    • University of Ulm, Clinic for Internal Medicine II, Ulm, Germany
    • ,
  • Peter Schauwecker, MD

      Affiliations

    • Institute of Transfusion Medicine and Institute of Clinical Transfusion Medicine and Immunogenetics, Ulm, Germany
    • ,
  • Fabian von Scheidt

      Affiliations

    • University of Ulm, Clinic for Internal Medicine II, Ulm, Germany
    • ,
  • Klaus Schwarz, MD

      Affiliations

    • Institute of Transfusion Medicine and Institute of Clinical Transfusion Medicine and Immunogenetics, Ulm, Germany
    • ,
  • Martin Bommer, MD

      Affiliations

    • University of Ulm, Clinic for Internal Medicine III, Ulm, Germany
    • ,
  • Markus Wiesneth, MD

      Affiliations

    • Institute of Transfusion Medicine and Institute of Clinical Transfusion Medicine and Immunogenetics, Ulm, Germany
    • ,
  • Hubert Schrezenmeier, MD

      Affiliations

    • Institute of Transfusion Medicine and Institute of Clinical Transfusion Medicine and Immunogenetics, Ulm, Germany
    • ,
  • Vinzenz Hombach, MD

      Affiliations

    • University of Ulm, Clinic for Internal Medicine II, Ulm, Germany

Received 1 September 2009 ,Revised 28 October 2009 ,Accepted 28 October 2009.

References 

  1. Schächinger V, Erbs S, Elsässer A, Haberbosch W, Hambrecht R, Hölschermann H, et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med. 2006;355:1210–1221
  2. Lunde K, Solheim S, Aakhus S, Arnesen H, Abdelnoor M, Egeland T, et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med. 2006;355:1199–1209
  3. Janssens S, Dubois C, Bogaert J, Theunissen K, Deroose C, Desmet W, et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet. 2006;367:113–121
  4. Tendera M, Wojakowski W, Ruzyllo W, Chojnowska L, Kepka C, Tracz W, et al. Intracoronary infusion of bone marrow-derived selected CD34+ CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial. Eur Heart J. 2009;30:1313–1321
  5. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet. 2004;364:141–148
  6. Meyer GP, Wollert KC, Lotz J, Steffens J, Lippolt P, Fichtner S, et al. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation. 2006;113:1287–1294
  7. Ge J, Li Y, Qian J, Shi J, Wang Q, Niu Y, et al. Efficacy of emergent transcatheter transplantation of stem cells for treatment of acute myocardial infarction (TCT-STAMI). Heart. 2006;92:1764–1767
  8. Huikuri HV, Kervinen K, Niemelä M, Ylitalo K, Säily M, Koistinen P, et al. Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction. Eur Heart J. 2008;29:2723–2732
  9. Dill T, Schächinger V, Rolf A, Möllmann S, Thiele H, Tillmanns H, et al. Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy. Am Heart J. 2009;157:541–547
  10. Martin-Rendon E, Brunskill SJ, Hyde CJ, Stanworth SJ, Mathur A, Watt SM. Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. Eur Heart J. 2008;29:1807–1818
  11. Meluzín J, Mayer J, Groch L, Janousek S, Hornácek I, Hlinomaz O, et al. Autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction: the effect of the dose of transplanted cells on myocardial function. Am Heart J. 2006;152:975;e9–975.15
  12. Hombach V, Grebe O, Merkle N, Waldenmaier S, Höher M, Kochs M, et al. Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging. Eur Heart J. 2005;26:549–557
  13. Britten MB, Abolmaali ND, Assmus B, Lehmann R, Honold J, Schmitt J, et al. Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation. 2003;108:2212–2218
  14. Wöhrle J, Nusser T, Hoffmann S, Kochs M. Angiographic results of the cobalt chromium vision and mini-vision stents. Can J Cardiol. 2009;25:581–584
  15. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115:2344–2351
  16. Bellenger NG, Burgess MI, Ray SG, Lahiri A, Coats AJ, Cleland JG, et al. Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable?. Eur Heart J. 2000;21:1387–1396
  17. Kang HJ, Lee HY, Na SH, Chang SA, Park KW, Kim HK, et al. Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial. Circulation. 2006;114(Suppl):I145–I151
  18. Ndrepepa G, Mehilli J, Martinoff S, Schwaiger M, Schömig A, Kastrati A. Evolution of left ventricular ejection fraction and its relationship to infarct size after acute myocardial infarction. J Am Coll Cardiol. 2007;50:149–156
  19. Engelmann MG, Theiss HD, Hennig-Theiss C, Huber A, Wintersperger BJ, Werle-Ruedinger AE, et al. Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infarction) trial. J Am Coll Cardiol. 2006;48:1712–1721
  20. Seeger FH, Tonn T, Krzossok N, Zeiher AM, Dimmeler S. Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction. Eur Heart J. 2007;28:766–772
  21. Menasche P. Cell-based therapy for heart disease: a clinically oriented perspective. Mol Ther. 2009;17:758–766

PII: S0002-9149(09)02680-0

doi: 10.1016/j.amjcard.2009.10.060

American Journal of Cardiology
Volume 105, Issue 6 , Pages 804-812 , 15 March 2010

Article Tools

* Image Usage & Resolution